Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors.
Mairs, Rob J
Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors. [electronic resource] - Seminars in nuclear medicine Sep 2011 - 334-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-4623
10.1053/j.semnuclmed.2011.03.004 doi
3-Iodobenzylguanidine--chemistry
Animals
Bystander Effect--drug effects
Cell Line, Tumor
Drug Interactions
Enzyme Inhibitors--pharmacology
Humans
Neuroendocrine Tumors--drug therapy
Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumors. [electronic resource] - Seminars in nuclear medicine Sep 2011 - 334-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-4623
10.1053/j.semnuclmed.2011.03.004 doi
3-Iodobenzylguanidine--chemistry
Animals
Bystander Effect--drug effects
Cell Line, Tumor
Drug Interactions
Enzyme Inhibitors--pharmacology
Humans
Neuroendocrine Tumors--drug therapy